ADAR1 Capital Management reports acquisition of $1.46 million in Tenax Therapeutics common shares
TENX•ADAR1 Capital Management reported buying 922,849 Tenax Therapeutics shares for about $1.46 million, increasing its reported indirect beneficial ownership to 7,447,000 shares.
1. Reported share purchases
ADAR1 Capital Management reported purchases of 922,849 Tenax Therapeutics common shares, increasing its reported indirect beneficial ownership to 7,447,000 shares. The purchases comprised 336,528 shares at $1.5066, 254,342 at $1.5952 and 331,979 at $1.6588. ADAR1 manager Daniel Schneeberger also reported indirect beneficial ownership; both reporting owners are listed as 10% owners.
